New Diabetes Drugs May Better Prevent Dementia Than Metformin
A new large study suggests that GLP-1 receptor agonists may be better than metformin at protecting the brain and lowering the risk of dementia in people with type 2 diabetes.
This research, published in BMJ Open Diabetes Research & Care, compared the effects of GLP-1 drugs and metformin on the brain. Both are commonly used to manage blood sugar in type 2 diabetes and have been shown to potentially protect the brain.
Researchers analyzed the health records of over 174,000 people with type 2 diabetes, with half taking GLP-1 drugs and the other half taking metformin, for at least six months. The results showed that about 2.5% of people taking GLP-1 drugs developed dementia, compared to nearly 5% of those on metformin.
GLP-1 receptor agonists may lower the risk of dementia in people with type 2 diabetes.
Author's summary: New diabetes medications may prevent dementia better than metformin.
More News
- ‘SNL’ recap: Best moments from Sabrina Carpenter hosting ‘Saturday Night Live’
- YOUR SUNDAY READING LIST: Emergency Nudity, ICE on Parade, and Portland's Hero Frogs
- Como 2-0 Juventus: Nico Paz puts toothless Old Lady to the torch
- Leylah Fernandez lifts fifth career title with Japan Open win
- Nico Paz decisive: Juve loses in Como before Bernabéu visit
- Keanu Reeves Just Responded to Those Alexandra Grant Marriage Rumors